Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 146

Results For "therapeutic"

1505 News Found

AIkido updates on use of machine learning in drug development orogram
Digitisation | August 09, 2021

AIkido updates on use of machine learning in drug development orogram

The goal for the project is the identification and optimization of anti-viral compounds.


Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets
Drug Approval | August 09, 2021

Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets

Both companies aim to improve the efficiency and success rate of the current drug discovery process.


FDA approves Nexviazyme for late-onset Pompe disease
Drug Approval | August 09, 2021

FDA approves Nexviazyme for late-onset Pompe disease

Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells


TAKE divests stake in Navitas Life Sciences to HIG
Biotech | August 08, 2021

TAKE divests stake in Navitas Life Sciences to HIG

The transaction is expected to close in the Q4FY22


Alkem launches Ibuprofen and Famotidine tablets in US
News | August 07, 2021

Alkem launches Ibuprofen and Famotidine tablets in US

Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis Tablets, 800 mg/26.6 mg


Sanofi to acquire Translate Bio
Biotech | August 07, 2021

Sanofi to acquire Translate Bio

Advances deployment of mRNA technology across vaccines and therapeutics development


Strides to acquire US manufacturing facility of Endo for $24 mn
News | August 06, 2021

Strides to acquire US manufacturing facility of Endo for $24 mn

The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.


Alembic gets USFDA nod for Clomipramine Hydrochloride
News | August 05, 2021

Alembic gets USFDA nod for Clomipramine Hydrochloride

It had an estimated market size of US $ 32 million as of June 2021


Alkem launch two drugs in US
News | August 04, 2021

Alkem launch two drugs in US

Ibuprofen and Famotidine tablets approved by FDA


Glenmark signs agreement with SaNOtize to manufacture NONS
News | August 02, 2021

Glenmark signs agreement with SaNOtize to manufacture NONS

The Phase III clinical trial for NONS is expected to be completed by Q4 2021.